Medication info
Isartan 150mg (Irbesartan)

Isartan 150mg (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
Myungjin Pharmaceutical Co., Ltd.
Appearance
Oval film-coated tablets, white or almost white
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200907798 · Notified 2009.10.29 · Insurance code 651903190

Summary

Main use
Treatment of essential hypertension and diabetic nephropathy associated with type 2 diabetes mellitus and hypertension
Who takes it
Adults
Adult dose
Dosage: This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer 150 mg of irbesartan orally once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special cases (such as at the start of treatment, in patients receiving hemodialysis, or in elderly patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive may be administered concomitantly. The effect is enhanced particularly when administered concomitantly with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive may be administered concomitantly to achieve the target blood pressure. ○ Elderly patients Dose adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in elderly patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg daily. However, there is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Myungjin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and diabetic nephropathy associated with type 2 diabetes mellitus and hypertension

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used for patients with hypertension, including essential hypertension. It also helps to prevent and manage kidney disease in patients with type 2 diabetes who have hypertension. Therefore, it is effective in controlling blood pressure and protecting kidney function.

How to take

Adult dose

Dosage: This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer 150 mg of irbesartan orally once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special cases (such as at the start of treatment, in patients receiving hemodialysis, or in elderly patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive may be administered concomitantly. The effect is enhanced particularly when administered concomitantly with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive may be administered concomitantly to achieve the target blood pressure. ○ Elderly patients Dose adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in elderly patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg daily. However, there is no clinical experience in patients with severe hepatic impairment.

Precautions

This drug can cause severe damage to the fetus during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. It should also be avoided in patients with severe liver dysfunction or certain genetic lactase metabolism disorders. Special caution is required for the elderly or patients with impaired kidney function, patients with hyperkalemia, etc., and regular blood tests and kidney function tests are necessary. This medication has blood pressure-lowering effects, so patients at risk of very low blood pressure or those with heart disease should take it carefully according to a doctor's instructions. Dizziness or fatigue may occur during treatment, so caution is needed when driving or operating machinery. There may be interactions if taken with other antihypertensive drugs or potassium supplements, so consultation with healthcare professionals is essential. This drug can rarely cause severe side effects like allergic reactions or angioedema, so if there is swelling of the face or lips or difficulty breathing, medical attention should be sought immediately. If unusual symptoms occur during use, it is important to inform a doctor or pharmacist and seek advice. Safety for use in children or adolescents has not been established, so it is recommended not to use in pediatric patients. Overdose may result in hypotension or cardiac arrhythmias, and appropriate treatment should be obtained as directed by a physician. This medication should be kept out of the reach of children and should not be transferred to other containers.

Side effects

  • Upper respiratory infection
  • sinus disorder
  • influenza
  • pharyngitis
  • rhinitis
  • musculoskeletal pain
  • myalgia
  • headache
  • dizziness
  • fatigue
Show 124 more
  • diarrhea
  • cough
  • nausea
  • vomiting
  • musculoskeletal trauma
  • chest pain
  • dyspepsia
  • heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety
  • irritability
  • upper urinary tract infection
  • fever
  • chills
  • facial edema
  • arm edema
  • flushing
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia
  • conduction abnormalities
  • respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • sexual dysfunction
  • sexual changes
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal distension
  • limb edema
  • muscle stiffness
  • arthritis
  • muscle weakness
  • sleep disorders
  • paralysis
  • hypersomnia
  • mood disorders
  • depression
  • sensory disturbances
  • tremors
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate disorder
  • epistaxis
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory disturbances
  • otitis
  • ear pain
  • conjunctivitis
  • eyelid disorder
  • ear disorder
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • elevated plasma creatine kinase
  • hyperkalemia
  • hypersensitivity reactions
  • rash
  • urticaria
  • angioedema
  • anaphylactic shock
  • anaphylactic reaction
  • weakness
  • dyspepsia
  • tinnitus
  • myalgia
  • elevated plasma creatine kinase
  • arthralgia
  • hepatitis
  • abnormal liver function
  • renal failure
  • psoriasis
  • photosensitivity reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • rhabdomyolysis
  • myalgia
  • malaise
  • elevated myoglobin in blood and urine
  • palpitations
  • constipation
  • dyspnea
  • sensory decrease
  • hypertriglyceridemia
  • insomnia
  • taste disturbance
  • polydipsia
  • abdominal distension
  • oral bleeding
  • increased sputum
  • decreased HDL
  • increased saliva
  • surface
  • itching
  • granulocytopenia
  • leukopenia
  • erectile dysfunction
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, preferably in a cool, dry place below 30 degrees Celsius.

Appearance and packaging

Appearance

Oval film-coated tablets, white or almost white

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.